GE HealthCare is in talks to acquire Sofie Biosciences for approximately $1 billion.
GE HealthCare Technologies is in negotiations to acquire Sofie Biosciences, a radiopharmaceutical developer, in a deal valued at approximately $1 billion. The talks were reported by the Financial Times on September 13, 2026, citing people familiar with the matter. Reuters attributed the report to the Financial Times.
0
Divergence score
2 outlets covered it, splitting into 2 framing camps across 2 bias groups.
2 camps
2 bias groups
Market signalBETA
The spectrum · how 2 outlets placed this story
LeftCenterRight
Financial Times
Reuters
Supportive of action
Neutral
Dismissive
Critical
Alarmist
International angle
Widest split · the two outlets furthest apart, and who published first
First to report
- Reutersfirst
- Financial Times+5.7 h
By each outlet's earliest publish time in this story. Feeds that index slowly can appear later than they printed.
The split, in one line
Both outlets report the same deal talks with no material divergence; Reuters simply attributes the scoop to the Financial Times.
How each outlet covered it
Lightly covered so far
Too few outlets to map a left-right split. Here is each take as it stands.
Sparse coverage · 2 outlets
“GE HealthCare in talks over possible $1 billion deal for Sofie Biosciences, FT reports”
“GE HealthCare in talks over $1bn deal for maker of cancer scan chemicals - Financial Times”
2 tracked claims across 2 outlets
Fact ledger
All2Claimed2
2/2
Claimed
GE HealthCare Technologies is in talks over a possible $1 billion deal to acquire Sofie Biosciences.
Corroborated
Disputed
1 more tracked claimSign up free to see the full ledger